These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
406 related articles for article (PubMed ID: 21489024)
1. Pharmacological inhibition of the hERG potassium channel is modulated by extracellular but not intracellular acidosis. DU CY; El Harchi A; Zhang YH; Orchard CH; Hancox JC J Cardiovasc Electrophysiol; 2011 Oct; 22(10):1163-70. PubMed ID: 21489024 [TBL] [Abstract][Full Text] [Related]
2. Acidification alters antiarrhythmic drug blockade of the ether-a-go-go-related Gene (HERG) Channels. Dong DL; Li Z; Wang HZ; Du ZM; Song WH; Yang BF Basic Clin Pharmacol Toxicol; 2004 May; 94(5):209-12. PubMed ID: 15125690 [TBL] [Abstract][Full Text] [Related]
4. Extracellular acidification and hyperkalemia induce changes in HERG inhibition by ibutilide. Lin C; Ke X; Ranade V; Somberg J Cardiology; 2008; 110(3):209-16. PubMed ID: 18057887 [TBL] [Abstract][Full Text] [Related]
5. The influence of extracellular acidosis on the effect of IKr blockers. Lin C; Ke X; Cvetanovic I; Ranade V; Somberg J J Cardiovasc Pharmacol Ther; 2005 Mar; 10(1):67-76. PubMed ID: 15821840 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of the current of heterologously expressed HERG potassium channels by flecainide and comparison with quinidine, propafenone and lignocaine. Paul AA; Witchel HJ; Hancox JC Br J Pharmacol; 2002 Jul; 136(5):717-29. PubMed ID: 12086981 [TBL] [Abstract][Full Text] [Related]
7. The [3H]dofetilide binding assay is a predictive screening tool for hERG blockade and proarrhythmia: Comparison of intact cell and membrane preparations and effects of altering [K+]o. Diaz GJ; Daniell K; Leitza ST; Martin RL; Su Z; McDermott JS; Cox BF; Gintant GA J Pharmacol Toxicol Methods; 2004; 50(3):187-99. PubMed ID: 15519905 [TBL] [Abstract][Full Text] [Related]
8. Inactivation gating determines drug potency: a common mechanism for drug blockade of HERG channels. Yang BF; Xu DH; Xu CQ; Li Z; Du ZM; Wang HZ; Dong DL Acta Pharmacol Sin; 2004 May; 25(5):554-60. PubMed ID: 15132818 [TBL] [Abstract][Full Text] [Related]
9. The Susceptibilities of Human Ether-à-Go-Go-Related Gene Channel with the G487R Mutation to Arrhythmogenic Factors. Hisajima N; Hata Y; Kinoshita K; Fukushima T; Nishida N; Kano M; Tabata T Biol Pharm Bull; 2015; 38(5):781-4. PubMed ID: 25947924 [TBL] [Abstract][Full Text] [Related]
10. A mechanism for the potential proarrhythmic effect of acidosis, bradycardia, and hypokalemia on the blockade of human ether-a-go-go-related gene (HERG) channels. Lin C; Cvetanovic I; Ke X; Ranade V; Somberg J Am J Ther; 2005; 12(4):328-36. PubMed ID: 16041196 [TBL] [Abstract][Full Text] [Related]
11. High affinity open channel block by dofetilide of HERG expressed in a human cell line. Snyders DJ; Chaudhary A Mol Pharmacol; 1996 Jun; 49(6):949-55. PubMed ID: 8649354 [TBL] [Abstract][Full Text] [Related]
12. The additive effects of the active component of grapefruit juice (naringenin) and antiarrhythmic drugs on HERG inhibition. Lin C; Ke X; Ranade V; Somberg J Cardiology; 2008; 110(3):145-52. PubMed ID: 18057881 [TBL] [Abstract][Full Text] [Related]
13. Altering extracellular potassium concentration does not modulate drug block of human ether-a-go-go-related gene (hERG) channels. Limberis JT; Su Z; Cox BF; Gintant GA; Martin RL Clin Exp Pharmacol Physiol; 2006 Nov; 33(11):1059-65. PubMed ID: 17042915 [TBL] [Abstract][Full Text] [Related]
14. Strategies to reduce HERG K+ channel blockade. Exploring heteroaromaticity and rigidity in novel pyridine analogues of dofetilide. Carvalho JF; Louvel J; Doornbos ML; Klaasse E; Yu Z; Brussee J; IJzerman AP J Med Chem; 2013 Apr; 56(7):2828-40. PubMed ID: 23473309 [TBL] [Abstract][Full Text] [Related]
15. Inhibitory effects of a bisbenzylisoquinline alkaloid dauricine on HERG potassium channels. Zhao J; Lian Y; Lu C; Jing L; Yuan H; Peng S J Ethnopharmacol; 2012 Jun; 141(2):685-91. PubMed ID: 21920426 [TBL] [Abstract][Full Text] [Related]
16. Structure-activity relationships of pentamidine-affected ion channel trafficking and dofetilide mediated rescue. Varkevisser R; Houtman MJ; Linder T; de Git KC; Beekman HD; Tidwell RR; Ijzerman AP; Stary-Weinzinger A; Vos MA; van der Heyden MA Br J Pharmacol; 2013 Jul; 169(6):1322-34. PubMed ID: 23586323 [TBL] [Abstract][Full Text] [Related]
17. Molecular determinants of cocaine block of human ether-á-go-go-related gene potassium channels. Guo J; Gang H; Zhang S J Pharmacol Exp Ther; 2006 May; 317(2):865-74. PubMed ID: 16397089 [TBL] [Abstract][Full Text] [Related]
18. Clemastine, a conventional antihistamine, is a high potency inhibitor of the HERG K+ channel. Ridley JM; Milnes JT; Hancox JC; Witchel HJ J Mol Cell Cardiol; 2006 Jan; 40(1):107-18. PubMed ID: 16288909 [TBL] [Abstract][Full Text] [Related]
19. F463L increases the potential of dofetilide on human ether-a-go-go-related gene (hERG) channels. Cheng G; Wu J; Han W; Sun C Microsc Res Tech; 2018 Jun; 81(6):663-668. PubMed ID: 29573040 [TBL] [Abstract][Full Text] [Related]
20. Comparative effects of liensinine and neferine on the human ether-a-go-go-related gene potassium channel and pharmacological activity analysis. Dong ZX; Zhao X; Gu DF; Shi YQ; Zhang J; Hu XX; Hu MQ; Yang BF; Li BX Cell Physiol Biochem; 2012; 29(3-4):431-42. PubMed ID: 22508050 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]